Authors of a new study measured differences in patient radiation exposure and the scatter effect among endoscopy personnel between the use of conventional and artificial intelligence-enabled fluoroscopy...
Because the treatment options for eosinophilic gastrointestinal disorders are limited, authors of the ENIGMA study evaluated whether the AK002 antibody could be a therapy option in eosinophilic gastritis...
Lindsay Sobotka, DO, from the Ohio State University Wexner Medical Center, presented her research at the ACG 2019 Annual Meeting about the risk of complications during pregnancy and outcomes among pregnant...
The authors of a new study presented at the ACG 2019 Annual Meeting examined the association between statin use and risk of HCC among more than 20,000 patients with HCC.
The authors of a new study presented at the ACG 2019 Annual Meeting evaluated data of more than 200 adult gastroenterology patients to characterize patients with avoidant/restrictive food intake disorder.
...
The researchers of a new phase 3 clinical trial presented at the ACG 2019 Annual Meeting sought to determine the safety and efficacy of budesonide oral suspension in adolescents and adults with EoE.
The authors of a new study evaluated more than 4000 cases of Campylobacter infection to estimate the US incidence of Campylobacter infection–associated postinfectious irritable bowel syndrome.
The FDA has expanded the approval of a new option for the treatment of adults and children aged 12 years or older or weighing at least 99 pounds with chronic hepatitis C virus genotypes 1, 2, 3, 4, 5, or 6...
Authors of a new study evaluated the impact of tenofovir disoproxil fumarate on outcomes of more than 1000 individuals with chronic hepatitis B virus infection with cirrhosis.
